Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-06), PT Kimia Farma Persero Tbk's 3-1 Month Momentum % is 5.61%.
The industry rank for PT Kimia Farma Persero Tbk's 3-1 Month Momentum % or its related term are showing as below:
ISX:KAEF's 3-1 Month Momentum % is ranked better than 66.67% of 126
companies
in the Medical Distribution industry
Industry Median: 1.365
vs ISX:KAEF: 5.61
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
PT Kimia Farma Persero Tbk 3-1 Month Momentum % Related Terms
ISX:KAEF vs MCK, COR, CAH: 3-1 Month Momentum % Comparison
For the Medical Distribution subindustry, PT Kimia Farma Persero Tbk's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Kimia Farma Persero Tbk 3-1 Month Momentum % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Persero Tbk's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where PT Kimia Farma Persero Tbk's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Kimia Farma Persero Tbk (ISX:KAEF) has a 3-1 Month Momentum % of 5.61% as of Sep. 06, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on PT Kimia Farma Persero Tbk and its competitors. According to the industry distribution chart, PT Kimia Farma Persero Tbk ranks #42 out of 126 companies in the Medical Distribution industry, placing it in the top 33.3%.
Is PT Kimia Farma Persero Tbk's 3-1 Month Momentum % too high?
PT Kimia Farma Persero Tbk's current 3-1 Month Momentum % is 5.61%. The Medical Distribution industry median 3-1 Month Momentum % is 1.37. PT Kimia Farma Persero Tbk's value of 5.61% is 311% above this industry median. Based on the distribution chart, PT Kimia Farma Persero Tbk ranks #42 out of 126 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, PT Kimia Farma Persero Tbk has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Persero Tbk's 3-1 Month Momentum % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Kimia Farma Persero Tbk ranks #42 out of 126 companies for 3-1 Month Momentum %. This puts PT Kimia Farma Persero Tbk in the upper half of its industry. The industry median 3-1 Month Momentum % is 1.37. PT Kimia Farma Persero Tbk's value of 5.61% is 311% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Distribution company?
The median 3-1 Month Momentum % among Medical Distribution companies is 1.37, based on 126 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Kimia Farma Persero Tbk's current 3-1 Month Momentum % of 5.61% is 311% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on PT Kimia Farma Persero Tbk and its competitors. For the Medical Distribution industry, the median 3-1 Month Momentum % is 1.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Kimia Farma Persero Tbk's current 3-1 Month Momentum % is 5.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Persero Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp579.29, compared to a current price of Rp440.00 — trading 24% below its estimated fair value. The current 3-1 Month Momentum % is 5.61% and 311% above the Medical Distribution industry median of 1.37. PT Kimia Farma Persero Tbk's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For PT Kimia Farma Persero Tbk (ISX:KAEF), the current 3-1 Month Momentum % is 5.61% as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Kimia Farma Persero Tbk (ISX:KAEF) Overvalued in 2026?
Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk stock appears to be undervalued.
The current stock price of Rp440.00 is trading 24% below its estimated GF Value™ of Rp579.29.
GuruFocus considers PT Kimia Farma Persero Tbk to be Modestly Undervalued.
Key valuation signals for ISX:KAEF:
3-1 Month Momentum %: 5.61%
GF Value™: Rp579.29 vs. price of Rp440.00 (24% below fair value)
Industry Position: 311% above the Medical Distribution median (#42 of 126)
No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
55GF Score
Get the complete analysis for ISX:KAEF
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:KAEF has been successfully added to your 
